Tower Research Capital LLC (TRC) - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 35 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$8
-99.9%
22,052
+44.0%
0.00%
Q3 2022$6,000
-53.8%
15,316
-45.0%
0.00%
Q2 2022$13,000
+550.0%
27,825
+813.8%
0.00%
Q1 2022$2,000
-33.3%
3,045
-38.5%
0.00%
Q4 2021$3,000
+200.0%
4,948
+494.7%
0.00%
Q3 2021$1,000
-90.9%
832
-90.5%
0.00%
Q2 2021$11,0000.0%8,733
+8.2%
0.00%
Q1 2021$11,000
-54.2%
8,070
+21.6%
0.00%
-100.0%
Q4 2020$24,000
+700.0%
6,634
+388.9%
0.00%
Q3 2020$3,000
+50.0%
1,357
+55.8%
0.00%
Q2 2020$2,000871
+254.1%
0.00%
Q1 2020$0
-100.0%
246
-98.6%
0.00%
-100.0%
Q4 2019$32,000
-17.9%
17,286
+27.6%
0.00%0.0%
Q3 2019$39,000
+105.3%
13,544
+83.9%
0.00%
+200.0%
Q2 2019$19,000
+46.2%
7,365
+46.8%
0.00%0.0%
Q1 2019$13,000
-48.0%
5,016
-44.0%
0.00%
-50.0%
Q4 2018$25,000
+150.0%
8,955
+732.2%
0.00%
+100.0%
Q3 2018$10,0001,0760.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 56,250$206,0000.12%
Baker Brothers Advisors 4,608,786$16,914,0000.06%
Artal Group S.A. 500,000$1,835,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 90,000$331,0000.04%
Spotlight Asset Group, Inc. 21,500$79,0000.03%
DCF Advisers, LLC 18,755$69,0000.03%
683 Capital Management, LLC 88,470$325,0000.02%
Palo Alto Investors LP 77,044$283,0000.02%
Alpine Global Management, LLC 13,966$51,0000.01%
TCI Wealth Advisors, Inc. 4,000$15,0000.01%
View complete list of IDERA PHARMACEUTICALS INC shareholders